As Coriell Life Sciences (CLS) leads the way in unlocking the power of pharmacogenomics (PGx) to improve lives and eliminate healthcare waste, the organization’s Corigen® Medication Safety Program has been named “Best Overall Genomics Solution” in the 2022 MedTech Breakthrough Awards. This year’s program attracted more than 3,900 nominations from over 15 different countries. [...]
Singular Genomics Systems reported a $22.0 million net loss for the first quarter 2022 after the close of the market on Tuesday. For the three months ended March 31, the San Diego-based sequencing technology firm, which raised $237.1 million in an initial public offering a year ago, reported no revenues as it prepares to [...]
Siemens Healthineers' molecular diagnostics business is seeking a partner to help it develop a next-generation testing platform that it plans to launch in Europe within three years to compete with high-volume testing systems currently in the market. As the company continues to develop, launch, and sell assays running on its existing Versant kPCR molecular [...]
Spatial proteomics firm Ionpath said on Wednesday that it has received a strategic investment of undisclosed size from Thermo Fisher Scientific. Ionpath has been developing multiplexed ion beam imaging (MIBI) technology for quantitative protein imaging with high sensitivity and subcellular resolution down to 350 nanometers. It uses metal-conjugated antibodies to tag proteins of interest [...]
Roche on Monday said its diagnostics sales during the first quarter grew 22 percent year over year. Roche as a whole, including both its pharmaceutical and diagnostics divisions, had CHF 16.45 billion ($17.16 billion) in sales in the quarter, up 10 percent from CHF 14.93 billion in Q1 of 2021. At constant exchange rates, [...]
The US Food and Drug Administration is preparing to open the next PrecisionFDA challenge, one looking at indel calling from oncopanel sequencing data. The PrecisionFDA program is working with the FDA's National Center for Toxicological Research (NCTR) to challenge the bioinformatics community to develop, validate, benchmark, and optimize indel calling pipelines from data produced [...]
NeoGenomics said on Monday that it will work with Eli Lilly on a program designed to provide no-cost genomic testing to patients with metastatic non-small cell lung cancer (NSCLC). Through the partnership, NSCLC patients eligible for the Lilly Lung Cancer Sponsored Testing Program will be tested using NeoGenomics' NeoType DNA and RNA Assay, a [...]
Yourgene Health said on Monday that it has extended its existing strategic partnership with Ambry Genetics with a new genomic services collaboration, which allows the companies mutual access to each other's technology and assays. Yourgene initially announced the partnership in 2021 but did not name Ambry at that time. The multi-year license and supply [...]
Tempus has ventured into a new market segment with its recent introduction of Edge, a platform that provides pathologists with online access to artificial intelligence models to identify samples with potentially significant biomarkers with a single hematoxylin and eosin-stained slide. The platform is meant to help physicians decide whether to order genomic sequencing that [...]
Qiagen has filed a lawsuit against Bio-Rad in a US federal court seeking a ruling that it has not infringed several Bio-Rad patents related to digital PCR technology. In a lawsuit filed on Wednesday in the US District Court for the District of Delaware, Qiagen stated that it is seeking declaratory judgment of non-infringement [...]
